To further investigate whether this is linked to oncogenic KRAS signaling, we analyzed OSBPL5 mRNA expression and KRAS mutation data in GDC (Genomic Data Commons) TCGA-PAAD, TCGA-LUNG, and TCGA-PANCAN, cohorts of pancreatic adenocarcinoma, non–small cell lung cancer, and a pan-cancer cohort comprising 33 different cancer types, respectively (Goldman et al, 2019Preprint). This evidence concerns the gene KRAS and cancer.